Anonymous
Guest
Anonymous
Guest
Little excuse can be granted the BOD who have been extremely late to trim back costs (legal issues notwithstanding). It has nearly bankrupt the company to finally accept that you cannot educate a urologist to behave like an oncologist no more than you can will a bird to be a fish. Urologists are highly adverse to risk, imagined or real. Most of our efforts have been focused on physicians who have already prescribed; trying to ferret out as much business as is readily possible. Mining these practices for patients is our best hope for near term revenue and I think there is considerable opportunity here. Nevertheless, there is enormous untapped opportunity from urologists who have yet to prescribe and we need to find a way to turn that around if we are going to beat the clock.